TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) currently has a daily average trading volume of 61.50K but it saw 2456104 shares traded in last market. With a market cap of 1.31M USD, the company’s current market price of $4.10 came rising about 17.14 while comparing to the previous closing price of $3.50. In past 52 weeks, the stock remained buoying in the range of price level as high as $138.00 and as low as $2.11. In the recent trading on the day, stock has struck highest price mark of $3.23 while lowest mark touched by it was $5.899.
Taking a look at 20-day trading activity of TC BioPharm (Holdings) plc ADR (TCBP) gives us an average price of $4.07, while its current price level is -97.03% below from 52-week high level whereas it is 94.30% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.70 while that of 200 days or SMA-200 reads an average of $20.62. A closer look into the stock’s movement over the week reveals that its volatility is standing at 25.76% during that period while stretching the period over a month that decreases to 25.50%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.55 which implies that the stock is in neutral territory.
Over the week, TCBP’s stock price is moving -4.87% down while it is -55.62% when we observe its performance for the past one month. Year-to-date it is -87.07% down and over the past year, the stock is showing a downside performance of -96.33%.
The company is expected to be releasing its next quarterly report on 2022-Dec-12, for which analysts forecasted an EPS of 0 while estimate for next year EPS is -2284.
Currently, TC BioPharm (Holdings) plc ADR’s total number of outstanding shares is 0.10M with 0.02% of that held by the insiders while 1.89% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -56.92% and return on equity (ROE) at -94.90%. Stock’s beta reads 0.07. Stock has a price to book (P/B) ratio of 60.65 while price to sale or P/S ratio amounts to 0.39. Its return on asset (ROA) is -13.34% on average.
